HOME > News > Event Recaps > 2024.1.26 Glac Biotech’s Year-End Celebration — Revenue Soars Over 30% as Leadership Champions the Future
2024.1.26 Glac Biotech’s Year-End Celebration — Revenue Soars Over 30% as Leadership Champions the Future
The end of the year is always a time for reflection, but this year, the atmosphere at Glac Biotech’s annual year-end banquet was electric. The hall buzzed with laughter, glasses clinking, and a shared sense of pride. Under the leadership of Chairman Lin Rong-Jin, the company had achieved something extraordinary: more than 30% growth in revenue in a single year.
This success didn’t happen by chance. For years, Glac has invested tens of millions into clinical research and probiotic development, relentlessly pursuing breakthroughs that few others dared to attempt. Those efforts paid off — not just in awards and recognition from global nutrition brands, but in hard numbers: orders have surged, revenues have climbed, and Glac’s position as a leader in the health industry has never been clearer.
As Chairman Lin took the stage, his words carried both pride and conviction. He spoke of how far the company had come, but more importantly, where it was going. He reminded everyone that each employee — from scientists in the lab to sales professionals in the field — was essential to this journey. His message was simple yet powerful: we’ve achieved greatness together, and together we will shape an even brighter tomorrow.
Building Trust Through Quality and Values
At the banquet, General Manager Huang Sheng-Hung echoed this vision. He emphasized that the company’s future does not rest solely on numbers, but on unwavering product quality and a steadfast commitment to core values. He encouraged every team member to keep pushing boundaries, never compromising on safety or excellence. Above all, he reiterated Glac’s mission: to protect public health and contribute meaningfully to society.
Celebrating the People Behind the Science
The evening also honored those who had walked alongside Glac for many years. Long-serving employees were recognized with Service Contribution Awards, a heartfelt thank-you for their dedication and loyalty. For many, it was a moment of joy — proof that their quiet commitment had built something lasting.
Science as a Flame for the Future
Sixteen years after its founding, Glac Biotech stands as one of Taiwan’s most committed probiotic innovators. To date, the company has successfully developed 16 probiotic solutions, each backed by science. In 2024, Glac embarked on a groundbreaking clinical study exploring the role of probiotics in Alzheimer’s disease, with findings already submitted to high-impact international journals. With over 3,200 clinical cases completed, Glac continues to lead where others in Asia can only look on.
Looking ahead, the company is determined to keep fueling this scientific passion, breaking new ground in probiotic and postbiotic research, and carrying Taiwan’s innovation onto the global stage. The year-end celebration wasn’t just a look back at a year of record-breaking growth — it was a promise of more milestones to come.
This success didn’t happen by chance. For years, Glac has invested tens of millions into clinical research and probiotic development, relentlessly pursuing breakthroughs that few others dared to attempt. Those efforts paid off — not just in awards and recognition from global nutrition brands, but in hard numbers: orders have surged, revenues have climbed, and Glac’s position as a leader in the health industry has never been clearer.
As Chairman Lin took the stage, his words carried both pride and conviction. He spoke of how far the company had come, but more importantly, where it was going. He reminded everyone that each employee — from scientists in the lab to sales professionals in the field — was essential to this journey. His message was simple yet powerful: we’ve achieved greatness together, and together we will shape an even brighter tomorrow.
Building Trust Through Quality and Values
At the banquet, General Manager Huang Sheng-Hung echoed this vision. He emphasized that the company’s future does not rest solely on numbers, but on unwavering product quality and a steadfast commitment to core values. He encouraged every team member to keep pushing boundaries, never compromising on safety or excellence. Above all, he reiterated Glac’s mission: to protect public health and contribute meaningfully to society.
Celebrating the People Behind the Science
The evening also honored those who had walked alongside Glac for many years. Long-serving employees were recognized with Service Contribution Awards, a heartfelt thank-you for their dedication and loyalty. For many, it was a moment of joy — proof that their quiet commitment had built something lasting.
Science as a Flame for the Future
Sixteen years after its founding, Glac Biotech stands as one of Taiwan’s most committed probiotic innovators. To date, the company has successfully developed 16 probiotic solutions, each backed by science. In 2024, Glac embarked on a groundbreaking clinical study exploring the role of probiotics in Alzheimer’s disease, with findings already submitted to high-impact international journals. With over 3,200 clinical cases completed, Glac continues to lead where others in Asia can only look on.
Looking ahead, the company is determined to keep fueling this scientific passion, breaking new ground in probiotic and postbiotic research, and carrying Taiwan’s innovation onto the global stage. The year-end celebration wasn’t just a look back at a year of record-breaking growth — it was a promise of more milestones to come.
 |  |
-
2023.7.31 Glac Biotech Shines at BioAsia Taiwan — Probiotic Innovations Spark Global Collaboration
-
2024.05.22 Brain Health Innovation Draws Global Attention — Glac Biotech Shines at Vitafoods Europe
-
2023.10.26 Totipro® PE0401 Steals the Spotlight at SSW — Glac Biotech’s Postbiotic Innovation Draws Global Attention
-
2024.5.10 Glac Biotech Becomes First Taiwanese Probiotic Manufacturer to Earn U.S. GRAS Certification